InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Smith Mary L., 董事. Insider active across 1 company, notably PTC Therapeutics, INC.. In total, 10 disclosures have been published. Split: 0 buy · 2 sells. Total volume traded: €1.2m. History available since 11 June 2021. The latest transaction was disclosed on 9 July 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Smith Mary L.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
10,000 股@ US$42.950.0061% mcap12.2% 占其流量Common StockSEC:0001866044-26-000005:0
10,000 股@ US$90.000.013% mcap25.5% 占其流量Common StockSEC:0001866044-26-000005:1
5,834 股@ US$42.950.0035% mcap7.1% 占其流量Common StockSEC:0001866044-26-000005:2
5,834 股@ US$90.000.0074% mcap14.9% 占其流量Common StockSEC:0001866044-26-000005:3
4,000 股0Common StockSEC:0001866044-26-000003:0
4,000 股0Common StockSEC:0001415889-25-001026:0
4,000 股0Common StockSEC:0001415889-24-004098:0
4,000 股0Common StockSEC:0001415889-23-000668:0
3,200 股0Common StockSEC:0001179110-22-000393:0
1,650 股0Common StockSEC:0001179110-21-006723:0
10 条申报中的 10 条
About Smith Mary L.
Smith Mary L. is Administrateur at PTC Therapeutics, INC. (XNAS). She has 10 filings in total, and across the 10 sampled filings from 2021-06-15 to 2026-07-13, sales amount to EUR 1247070 and purchases to EUR 0, with the modal transaction nature listed as Attribution.
